Picton Mahoney Asset Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Picton Mahoney Asset Management’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-700	Closed	-$70K	–	223
2016 Q3	$70K	Sell	700 -200	-22%	-$19.6K	﹤0.01%	253
2016 Q2	$80K	Hold	900	–	–	﹤0.01%	273
2016 Q1	$79K	Hold	900	–	–	0.01%	285
2015 Q4	$102K	Hold	900	–	–	0.01%	238
2015 Q3	$91K	Buy	900 +400	+80%	+$47.6K	0.01%	233
2015 Q2	$62K	Hold	500	–	–	﹤0.01%	283
2015 Q1	$59K	Buy	500 +100	+25%	+$11.3K	﹤0.01%	281
2014 Q4	$41K	Buy	+400	New	+$39.1K	﹤0.01%	279
2014 Q3	–	Sell	-1,500	Closed	-$123	–	323
2014 Q2	$123	Buy	1,500 +100	+7%	+$7.64K	0.01%	248
2014 Q1	$107K	Buy	+1,400	New	+$109K	0.01%	302

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

JPCCM

J&P (China) Capital Management Hong Kong, China $586M AUM 82.64% 1-Year Est. Return

MCWS

McKinley Carter Wealth Services Wheeling, West Virginia $1.73B AUM 17.28% 1-Year Est. Return

Picton Mahoney Asset Management's FBT Position: Q4 2016 in Review

Picton Mahoney Asset Management sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q4 2016, closing a stake of 700 shares — an estimated $70K sold.

Picton Mahoney Asset Management first reported a position in FBT in Q1 2014 and held it in 10 quarters. The position peaked at $107K in Q1 2014. 109 funds tracked by Wall St. Rank hold FBT as of Q4 2016.

Picton Mahoney Asset Management reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q4 2016 after selling out during the quarter.
Picton Mahoney Asset Management sold 700 First Trust NYSE Arca Biotechnology Index Fund shares in Q4 2016, an estimated $70K.
Picton Mahoney Asset Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2014 and held it in 10 quarters.
Picton Mahoney Asset Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $107K in Q1 2014.
109 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q4 2016.

Based on Picton Mahoney Asset Management's 13F filing for Q4 2016, filed 15 Feb 2017.